The Technical Accelerator Award (Vaccines and Therapeutics) supports research and development of vaccines and therapeutics to prevent and alleviate the infection, progression, and spread of endemic or emerging infectious diseases in low- and middle-income countries. The amount of support is KRW 500 million per project, and at least one Korean corporation must be included as a lead institution or public research organization.

For more detailed information, please refer to the attached document.